Study: Treatment of pulmonary fibrosis should focus on the telomeres of the cells that regenerate the lungs
Idiopathic pulmonary fibrosis could become the first degenerative disease to be treated through the science of aging.
Oct 6, 2022
0
54
Idiopathic pulmonary fibrosis could become the first degenerative disease to be treated through the science of aging.
Oct 6, 2022
0
54
In the last decade, timely and efficient diagnoses of idiopathic pulmonary fibrosis (IPF), a lethal disease that causes scarring of the lung tissue and affects the ability to breathe and be active, has become recognized as ...
Sep 29, 2022
0
17
A steering committee of pulmonary experts and primary care physicians (PCPs) released today a white paper outlining the issues surrounding delays in diagnosing interstitial lung diseases (ILDs) like pulmonary fibrosis (PF). ...
Sep 19, 2022
0
6
An experimental cancer drug with a favorable safety profile shows promise as a treatment for Idiopathic Pulmonary Fibrosis (IPF), according to a study published on August 23, 2022, in the American Journal of Respiratory and ...
Sep 1, 2022
0
301
A Nagoya University research group has developed an AI algorithm that accurately and quickly diagnoses idiopathic pulmonary fibrosis, a lung disease. The algorithm makes its diagnosis based only on information from non-invasive ...
Jul 28, 2022
0
5
The QUT Inspire ISy app, was developed by QUT Ph.D. candidate Clarence Baxter and has been tested and compared with a Triflo II clinical incentive spirometry device by 24 healthy participants with the study's results published ...
Jul 28, 2022
0
7
A new diagnostic method could help identify one of the deadliest types of interstitial lung disease (ILD) sooner, allowing for faster treatment and improved patient outcomes.
Jul 26, 2022
0
6
Idiopathic pulmonary fibrosis (IPF) is an aging-associated disease caused by progressive scarring of the lungs, leading to respiratory failure and death. Therapies to treat IPF are limited, making studies on the mechanisms ...
Jul 25, 2022
0
91
While most people recover from COVID-19 within a week or two, up to one-third of survivors experience persistent or new symptoms weeks and months after initial infection.
Jul 20, 2022
0
102
A promising avenue of research into chronic lung disease treatment has hit a speed bump, with a new study showing that 3D manufacturing mesenchymal stem cells (MSCs) may not be the panacea hoped for by researchers.
Jun 6, 2022
0
16